Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
INMB - STOCK-BASED COMPENSATION
Stock-based Compensation INMB - INmune Bio, Inc.
7.37 M
LAST VALUE
23.95%
2 YEAR CAGR
-5.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR